METHOCARBAMOL TABLE

The Defense Logistics Agency awarded a single-line delivery order, SPE2DP26F7492, to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0), a small, women-owned, and small disadvantaged business, for one bottle of Methocarbamol Tablets (NSN 6505006601601, NDC 51407-0467-05) at a fixed unit price of $12.66, resulting in a total contract value of $12.66. This order was issued under the basic indefinite-delivery, indefinite-quantity contract SPE2DX25D9900 and requires delivery FOB destination to Fort Stewart, Georgia, by July 29, 2026, with no tolerance for quantity variance. The contractor is responsible for all shipping costs and must use traceable transportation methods, excluding parcel post, while marking all shipments with the traceable control number W33RBS61060264. Inspection and acceptance occur at the destination by the Government, under the terms of the parent contract, with compliance required to the DoD unit of issue standards and applicable contractual conditions. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using voucher-based systems consistent with DoD financial procedures. No specific packaging, preservation, or labeling standards beyond traceable marking are detailed, and no barcoding, MIL-STD, or technical specifications beyond NSN and NDC identifiers are provided. The award reflects a price-based, Low Price Technically Acceptable approach, supported by the contractor’s affirmed socioeconomic statuses and absence of technical evaluation criteria. The contracting officer is Lisa Quinn, with Shairy M. Cartagena serving as local administrator, while no dedicated COR or COTR is designated. The contract does not include any explicitly listed FAR clauses, attachments, or evaluation factors beyond the basic terms of the underlying basic contract.